BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//c-myc - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:c-myc
X-ORIGINAL-URL:https://cmyc.w.uib.no
X-WR-CALDESC:Events for c-myc
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Oslo
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20260507T080000
DTEND;TZID=Europe/Oslo:20260508T170000
DTSTAMP:20260528T044315
CREATED:20260325T093841Z
LAST-MODIFIED:20260325T093935Z
UID:1167-1778140800-1778259600@cmyc.w.uib.no
SUMMARY:CMYC Workshop: Statistics in Clinical Trials
DESCRIPTION:CMYC Workshop: Statistics in Clinical Trials
URL:https://cmyc.w.uib.no/event/workshop-statistics-in-clinical-trials/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20260504T080000
DTEND;TZID=Europe/Oslo:20260506T170000
DTSTAMP:20260528T044315
CREATED:20260311T151515Z
LAST-MODIFIED:20260311T151519Z
UID:1157-1777881600-1778086800@cmyc.w.uib.no
SUMMARY:SBMC 2026 Conference - "From Data and Models to E-Health"
DESCRIPTION:More info: please visit SBMC 2026
URL:https://cmyc.w.uib.no/event/sbmc-2026-conference-from-data-and-models-to-e-health/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20260423T143000
DTEND;TZID=Europe/Oslo:20260423T153000
DTSTAMP:20260528T044315
CREATED:20260413T075244Z
LAST-MODIFIED:20260413T082355Z
UID:1220-1776954600-1776958200@cmyc.w.uib.no
SUMMARY:CMYC and CCBIO joint seminar - Richard Dillon
DESCRIPTION:MRD in AML — what\, where\, when\, and does it matter?\n\n\n\n\nSpeaker: Richard Dillon\, Clinical Senior Lecturer in Cancer Genetics in the Department of Medical & Molecular Genetics\, School of Basic & Medical Biosciences\, at King’s College London and Consultant Haematologist at Guy’s Hospital\, London\, UK \n\n\n\nPlace: Auditorium 4\, BB-building \n\n\n\nWhen: April 23\, 2026\, at 14.30–15.30 \n\n\n\nChair: Bjørn Tore Gjertsen \n\n\n\n\nCMYC and CCBIO Joint Seminar – Richard Dillon
URL:https://cmyc.w.uib.no/event/cmyc-and-ccbio-joint-seminar-richard-dillon/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20260220T101500
DTEND;TZID=Europe/Oslo:20260220T120000
DTSTAMP:20260528T044315
CREATED:20260206T143128Z
LAST-MODIFIED:20260211T115622Z
UID:1110-1771582500-1771588800@cmyc.w.uib.no
SUMMARY:CMYC Seminar by Assoc. Prof. Francesca Sacco and Kim Theilgaard-Mönch
DESCRIPTION:Avenue: Auditorium 4\, BB-bygget \n\n\n\n10:15 –11:00 Assoc. Prof. Francesca Sacco\, Department of Biology\, University of Rome Tor Vergata“A systems biology approach to identify vulnerabilities in therapy-resistant leukemias“ \n\n\n\n11:00 – 12:00 Assoc. Prof. Kim Theilgaard-Mönch\, Biotech Research & Innovation Centre\, University of Copenhagen“The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy of acute myeloid leukemia“ \n\n\n\nFor more info: https://cmyc.w.uib.no/2026/02/06/cmyc-seminar/
URL:https://cmyc.w.uib.no/event/cmyc-seminar-by-assoc-prof-francesca-sacco-and-kim-theilgaard-monch/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20260219T101500
DTEND;TZID=Europe/Oslo:20260219T150000
DTSTAMP:20260528T044315
CREATED:20260206T144214Z
LAST-MODIFIED:20260206T144218Z
UID:1115-1771496100-1771513200@cmyc.w.uib.no
SUMMARY:PhD Defense: Inga Kirstine Flaaten Motzfeldt
DESCRIPTION:Inga Kirstine Flaaten Motzfeldt is presenting and defending for ph.d.-degree at the University of Bergen\, with her thesis \n\n\n\n“Exploration of Disease Mechanisms and Targeted Therapies in Acute Myeloid Leukemia”.\n\n\n\nTime: 12.15–15.00 \n\n\n\nLocation: HUS – BB-bygget\, Auditorium 1 \n\n\n\nTrial lecture: “Functional Precision Oncology – Phosphoproteomics-guided targeting of oncogenic kinases in AML”\n\n\n\nTime: 10.15–11.00 \n\n\n\nPlace: HUS – BB-bygget\, Auditorium 2 \n\n\n\nFor more information: https://www.uib.no/nye-doktorgrader/181434/ny-kunnskap-om-blodkreft-kan-gi-mer-treffsikker-behandling
URL:https://cmyc.w.uib.no/event/phd-defense-inga-kirstine-flaaten-motzfeldt/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20260212T080000
DTEND;TZID=Europe/Oslo:20260213T170000
DTSTAMP:20260528T044315
CREATED:20251105T150332Z
LAST-MODIFIED:20251105T150336Z
UID:971-1770883200-1771002000@cmyc.w.uib.no
SUMMARY:CMYC Lab Retreat
DESCRIPTION:The next coming CMYC Lab Retreat will be held on February 12–13\, 2026 at Solstrand Hotel & Bad\, Bergen. \n\n\n\nAt the retreat\, Master’s students\, PhD candidates\, and postdocs/researchers in CMYC will present and discuss about their thesis or project. The purpose of the retreat is to strengthen team building through interaction between junior and senior members\, postdocs\, and principal investigators\, as well as to provide feedback\, re-evaluate projects\, brainstorm new ideas and plan for next steps. \n\n\n\nA detailed program and practical information will be coming later. \n\n\n\nFor registration: link \n\n\n\nThe deadline to register is January 16th (the sooner\, the better)
URL:https://cmyc.w.uib.no/event/cmyc-lab-retreat/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20251217T150000
DTEND;TZID=Europe/Oslo:20251217T170000
DTSTAMP:20260528T044315
CREATED:20251210T090032Z
LAST-MODIFIED:20251210T090036Z
UID:1080-1765983600-1765990800@cmyc.w.uib.no
SUMMARY:Webinar: Personalized Medicine in the Treatment of AML
DESCRIPTION:You are invited to join a distinguished academic webinar featuring Prof. Dr. med. Lars Bullinger and Prof. Bjørn Tore Gjertsen\, two leading experts in hematology and leukemia research. The webinar is hosted by Jazz Pharmaceuticals \n\n\n\nFor registration: Please sign up using this Link
URL:https://cmyc.w.uib.no/event/webinar-personalized-medicine-in-the-treatment-of-aml/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20251118T101500
DTEND;TZID=Europe/Oslo:20251118T150000
DTSTAMP:20260528T044315
CREATED:20251106T110409Z
LAST-MODIFIED:20251106T110906Z
UID:977-1763460900-1763478000@cmyc.w.uib.no
SUMMARY:PhD Defense: Tara Helén Steinsland Dowling
DESCRIPTION:Tara Helén Steinsland Dowling is presenting and defending for ph.d.-degree with her thesis \n\n\n\n“Acute myeloid leukemia at single-cell resolution: Clonal heterogeneity in precision therapy”\n\n\n\nTrial lecture: “Relevance of clonal hematopoiesis in hematological malignancies”\n\n\n\nTime: 10.15–11.00 \n\n\n\nPlace: HUS – BB-bygget\, Auditorium 2 \n\n\n\nDefense\n\n\n\nTime: 12.15–15.00 \n\n\n\nLocation: HUS – BB-bygget\, Auditorium 2 \n\n\n\nFor more information: https://www.uib.no/nye-doktorgrader/180253/krigen-mellom-klonane-det-klonale-landskapet-i-aml
URL:https://cmyc.w.uib.no/event/phd-defense/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20251113T143000
DTEND;TZID=Europe/Oslo:20251113T153000
DTSTAMP:20260528T044315
CREATED:20251113T093610Z
LAST-MODIFIED:20251113T094238Z
UID:984-1763044200-1763047800@cmyc.w.uib.no
SUMMARY:CCBIO and CMYC seminar
DESCRIPTION:“Stress for success”: Unlocking Venetoclax sensitivity in T-ALL through the mTORC1–ISR–BMF axis.\n\n\n\nby Prof. Vincenzo Ciminale\, MD\, Istituto Oncologico Veneto\, Padova\, Italy\n\n\n\n\n\nWhen: Thursday\, 13.11.2025\, 14.30–15.30 \n\n\n\nWhere: Aud. 4\, BBB \n\n\n\nHost: Bjørn Tore Gjertsen \n\n\n\nAbstract\n\n\n\nRefractory/relapsed T-cell acute lymphoblastic leukemia (R/R T-ALL) remains a major therapeutic challenge at present. Our recent studies showed that inhibition of mTORC1 markedly sensitizes T-ALL cell lines and patient-derived xenografts (PDXs) to the BCL-2 inhibitor Venetoclax. RNAseq\, gene set enrichment analysis\, and analysis of the temporal trajectories of response to the mTORC1 inhibitor Everolimus revealed that induction of cell death was dependent on sustained engagement of the integrated stress response (ISR)\, resulting in induction of BMF\, a proapoptotic protein of the BCL-2 family. The effects on cell death were phenocopied by the bisteric mTORC1 inhibitor RMC6272 or by genetic silencing of the mTORC1 cofactor Raptor. Genetic silencing of the ISR master regulator ATF4 also phenocopied these effects\, confirming ISR engagement as a critical mediator of cytotoxicity. Conversely\, epigenetic silencing or siRNA-mediated knockdown of BMF conferred resistance to Everolimus\, whereas histone deacetylase inhibition restored BMF expression and drug sensitivity. Combined treatment with Everolimus and Venetoclax elicited potent\, ISR-dependent antitumor activity in vivo. \n\n\n\nThese findings provide insight into the links between mTORC1 and the ISR and furnish proof-of-concept evidence for mTORC1 inhibition and sustained ISR activation as a viable strategy to overcome Venetoclax resistance to in T-ALL. Expression of BMF\, a key mediator of this process\, could predict response to this combination therapy. \n\n\n\nRead more on CCBIO’s website.
URL:https://cmyc.w.uib.no/event/ccbio-and-cmyc-seminar/
CATEGORIES:Networking Activities,Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20251022T140000
DTEND;TZID=Europe/Oslo:20251022T150000
DTSTAMP:20260528T044315
CREATED:20251006T080039Z
LAST-MODIFIED:20251006T080433Z
UID:929-1761141600-1761145200@cmyc.w.uib.no
SUMMARY:CMYC-Seminar: "The dual specificity MAP kinase phosphatase DUSP2 acts as distal regulatory node in T Cell signalling” by Professor Ole Morten Seternes
DESCRIPTION:Welcome to the upcoming seminar holdt by Professor Ole Morten Seternes\, Group Leader of the Cell Signalling and Targeted Therapy Research Group\, Department of Pharmacy\, UIT The Arctic University of Norway. \nTittle: The dual specificity MAP kinase phosphatase DUSP2 acts as distal regulatory node in T Cell signalling \nTime: 22nd October 2025. 14:00 – 15:00 \nPlace: Room B307\, 3rd floor\, Sentralblokken\, Haukeland University Hospital \nAbstract: \nThe dual-specificity MAP kinase phosphatases (MKPs) family plays a critical role in the dephosphorylation and inactivation of various MAP kinases in mammalian cells and tissues. MKPs not only provide a mechanism for spatiotemporal feedback control of these essential signalling pathways but also facilitate crosstalk between distinct MAP kinase pathways and other key signalling modules. The ten mammalian MKPs differ in their substrate specificity and subcellular localization. Several MKPs have been implicated in regulating MAPK signalling in T cells. However\, studies utilizing genetic mouse models have yielded conflicting results regarding which MKP members contribute to this regulation. This prompted us to re-examine the role of MKPs in controlling MAPK signalling using a human T cell model. Our findings suggest that DUSP2 regulates early MAPK activation in these cells and may function as a part of a distal regulatory node in T cell signalling.
URL:https://cmyc.w.uib.no/event/cmyc-seminar-the-dual-specificity-map-kinase-phosphatase-dusp2-acts-as-distal-regulatory-node-in-t-cell-signalling-by-professor-ole-morten-seternes/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20251016T080000
DTEND;TZID=Europe/Oslo:20251018T170000
DTSTAMP:20260528T044315
CREATED:20251105T124511Z
LAST-MODIFIED:20251114T091423Z
UID:964-1760601600-1760806800@cmyc.w.uib.no
SUMMARY:ESHAML2025
DESCRIPTION:7th International Conference: Acute Myeloid Leukemia “Molecular and Translational”: Advances in Biology and Treatment\nEstoril\, Portugal  \n\n\n\n\nPresentations by CMYC participants at the conferences
URL:https://cmyc.w.uib.no/event/eshaml2025/
CATEGORIES:Conference,Networking Activities
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20251010T080000
DTEND;TZID=Europe/Oslo:20251012T170000
DTSTAMP:20260528T044315
CREATED:20251105T130940Z
LAST-MODIFIED:20251113T120110Z
UID:968-1760083200-1760288400@cmyc.w.uib.no
SUMMARY:ESHCML2025
DESCRIPTION:ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy \n\n\n\nEstoril\, Portugal – #ESHCML2025 \n\n\n\nPresentations by CMYC participants at the conferences
URL:https://cmyc.w.uib.no/event/eshcml2025/
CATEGORIES:Conference,Networking Activities
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250910
DTEND;VALUE=DATE:20250913
DTSTAMP:20260528T044315
CREATED:20250523T114247Z
LAST-MODIFIED:20250523T114247Z
UID:670-1757462400-1757721599@cmyc.w.uib.no
SUMMARY:Nordic AML Group Meeting 2025
DESCRIPTION:We are delighted to invite you to Bergen\, Norway\, for the upcoming Nordic AML Meeting\, taking place in September 10-12\, 2025. \nSet against the breathtaking backdrop of Bergen’s stunning fjords and vibrant cultural heritage\, this event will bring together leading minds\, practitioners\, and innovators in the field of AML. It is an unparalleled opportunity to share knowledge\, foster collaboration\, and explore the latest advances in research and treatment strategies. \nSave the dates and join us for an inspiring program filled with impactful discussions\, cutting-edge insights\, and the chance to connect with colleagues from across the Nordic region and beyond. \nWe look forward to welcoming you to Bergen for this exciting meeting! \n\n\nRegister here. \nRegistration deadline: 1st of August. \nRead more at: https://www.namlg.org/namlg-bergen-2025/ \n 
URL:https://cmyc.w.uib.no/event/nordic-aml-group-meeting-2025/
LOCATION:Hotel Norge by Scandic\, Nedre Ole Bullsplass 4\, Bergen\, Norway
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20250821T130000
DTEND;TZID=Europe/Oslo:20250821T140000
DTSTAMP:20260528T044315
CREATED:20250825T082049Z
LAST-MODIFIED:20250825T082049Z
UID:738-1755781200-1755784800@cmyc.w.uib.no
SUMMARY:c-myc Seminar
DESCRIPTION:13:00 –Assoc. Prof. Morten Rye\, Dept. of Clinical and Molecular Medicine\, NTNU: Spatial Transcriptomics Analysis of Prostate Cancer \nThe cancerous prostate gland is a heterogenous mix of different cancer and normal cells and tissue types\, which is a major source of confounding when large scale molecular – omics analysis is performed on the prostate gland. One way to delineate this heterogeneity is Spatial Transcriptomics\, which can generate individual tissue specific gene expression profiles from thousands of spots placed on a grid across a prostate cancer tissue slice (see illustration). A major clinical challenge in prostate cancer is the ability to distinguish aggressive and non-aggressive prostate cancer in the cancer care pathway\, and Spatial Transcriptomics could be a technology to do more precise molecular diagnostics of prostate cancer. With this in mind\, our Prostomics research group generated spatial transcriptomics datasets (Visium 10x Genomics) on 32 tissue samples from 8 prostate cancer patients\, 5 containing aggressive and 3 containing non- aggressive cancers. Samples were taken specifically from cancer\, cancer-adjacent and distant normal tissue regions\, and spots where classified according to their content of cancer\, extracellular matrix/stroma and normal tissue\, and further analysed by Gene Set Enrichment Analysis. Our analysis discovered that normal appearing tissue adjacent to aggressive cancer regions lose prostate specific functions and adapt properties resembling cell-types which are not expected to be present in a healthy prostate gland. \n  \n13:20 –Prof. Berit Johansen\, Dept. of Biology\, NTNU: Treating cancer and leukemia: A new way to trigger cell self-destruction \nThe polyunsaturated fatty acid arachidonic acid (AA) and its metabolites\, eicosanoids\, i.e. prostaglandins\, thromboxanes\, leukotrienes\, etc.\, have attracted considerable interest in relation to inflammatory processes and diseases\, including cancer (leukemia)\, cardiovascular and autoimmune diseases\, and metabolic disorders. AA is generated by the action of phospholipase A2 (PLA2)\, which catalyzes its hydrolytic cleavage from membrane glycerophospholipids. PLA2 enzymes constitute a superfamily of enzymes\, divided into many groups and subgroups. Among them\, cytosolic Group IVA PLA2 (cPLA2α) plays a critical role in the release of AA and is the most well-studied PLA2 in inflammation. Targeting eicosanoid production by inhibiting cPLA2α offers a promising approach for inflammation or cancer therapy. Our findings imply cPLA2α may support cancer by mitigating oxidative stress and inhibiting tumor suppressor expression suggesting that the very specific and sensitive cPLA2α -inhibitors we have developed\, has potential for treating acute leukemias and other cancers by introducing programmed cell death.
URL:https://cmyc.w.uib.no/event/c-myc-seminar/
LOCATION:Birkhaugsalen (D303)\, 3rd floor\, Central Block\, Haukeland University Hospital
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20250821T101500
DTEND;TZID=Europe/Oslo:20250821T140000
DTSTAMP:20260528T044315
CREATED:20250819T123626Z
LAST-MODIFIED:20250819T124431Z
UID:689-1755771300-1755784800@cmyc.w.uib.no
SUMMARY:Master's Degree Examination for Stine Haugstvedt
DESCRIPTION:Stine Haugstvedt will present and defend her Master’s thesis: \n“Optimizing single-cell and immune profiling of asciminib-treated chronic myeloid leukemia patients using mass cytometry” \n\nDate: Thursday\, August 21\nTime: 10:15 AM\nLocation: Birkhaugsalen\, D305\, 3rd floor\, Central Block\, Haukeland University Hospital\n\nSupervisors: \n\nAssoc. Prof. Morten Beck Rye (NTNU)\nProf. Bjørn Tore Gjertsen (UiB)\nDr. Stein-Erik Gullaksen (UiB)\n\nInternal Examiner: Prof. Berit Johansen (NTNU)\nExternal Examiner: Dr. David Micklem (BerGenBio) \nPresentations Following the Master’s Examination \n\n13:00 –Assoc. Prof. Morten Beck Rye\, Dept. of Clinical and Molecular Medicine\, NTNU\nSpatial Transcriptomics Analysis of Prostate Cancer\n13:20 –Prof. Berit Johansen\, Dept. of Biology\, NTNU\nTreating cancer and leukemia: A new way to trigger cell self-destruction
URL:https://cmyc.w.uib.no/event/masters-degree-examination-for-stine-haugstvedt/
LOCATION:Birkhaugsalen (D303)\, 3rd floor\, Central Block\, Haukeland University Hospital
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250521
DTEND;VALUE=DATE:20250522
DTSTAMP:20260528T044315
CREATED:20250521T090022Z
LAST-MODIFIED:20250521T090022Z
UID:596-1747785600-1747871999@cmyc.w.uib.no
SUMMARY:Møte i Brukerutvalget
DESCRIPTION:Program/saksliste \n1700-1730:       «Generell informasjon om brukermedvirkning» med Merete Eide Hernes og Trude Hjortland Fra Seksjon for samhandling\, Helse Bergen \n1730-1745:        «Dendrittcellevaksine ved KML» ved Morten Yong Isaksen \n1745-1800:       «The Hovon 135 study : a Single cell approach» ved Oriol Castell \n1800-1810:       Pause \n1810-1830:       Brukerutvalgets rolle og mandat i C-MYC ved Roger Strand \n1830-1840:       Status oppdatering fra C-MYC senteret ved Bjørn Tore Gjertsen
URL:https://cmyc.w.uib.no/event/mote-i-brukerutvalget/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20250519T140000
DTEND;TZID=Europe/Oslo:20250519T144500
DTSTAMP:20260528T044315
CREATED:20250522T115327Z
LAST-MODIFIED:20250522T115437Z
UID:652-1747663200-1747665900@cmyc.w.uib.no
SUMMARY:Innovasjonsseminar
DESCRIPTION:Er du nysgjerrig på gründerskap og innovasjon? \nVil du bli inspirert av en ekspert på fagfeltet? \nForedragsholder: Sjur Dagestad\nTid: 19. Mai 2025 kl 14.00-14.45\nSted: Birkhaugssalen\, Sentralblokken\, HUS \nSjur Dagestad vil ta oss med på en liten rundreise innen faget innovasjon. Sjur har jobbet med innovasjon siden 1988\, både som gründer\, leder og professor. Han var første vinner av Reodorprisen\, har ledet Tomras satsning på radikal innovasjon og vært med på å starte flere selskaper. Han har skrevet åtte innovasjonsfaglige bøker og leder for tiden Norges største innovasjonsfaglige dypdykk\, med 185 deltakere. Sjur vil komme inn på noen grunnleggende sider ved gründerskap\, forskjellen på forskning og innovasjon og hvorfor det enkle ofte er det vanskeligste.
URL:https://cmyc.w.uib.no/event/innovasjonsseminar/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250512
DTEND;VALUE=DATE:20250513
DTSTAMP:20260528T044315
CREATED:20250521T085606Z
LAST-MODIFIED:20250521T085606Z
UID:599-1747008000-1747094399@cmyc.w.uib.no
SUMMARY:c-myc Single Cell Satellite Seminar 2025
DESCRIPTION:
URL:https://cmyc.w.uib.no/event/c-myc-single-cell-satellite-seminar-2025/
LOCATION:Solstrand Hotel & Bad\, Solstrandvegen 200\, Os\, 5200\, Norway
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20250424T143000
DTEND;TZID=Europe/Oslo:20250424T153000
DTSTAMP:20260528T044315
CREATED:20250522T114805Z
LAST-MODIFIED:20250522T114805Z
UID:648-1745505000-1745508600@cmyc.w.uib.no
SUMMARY:CCBIO seminar – Stein-Erik Gullaksen
DESCRIPTION:Welcome to the CCBIO seminar series in the spring term of 2025. Open to all in auditorium 4\, BBB. No registration necessary. Speaker is Stein-Erik Gullaksen from CCBIO/UiB\, on the topic “Deep single cell immune and signaling profiling hours after starting treatment predict response to treatment in patients with Chronic myeloid leukemia.” \nRead more on CCBIO’s website.
URL:https://cmyc.w.uib.no/event/ccbio-seminar-stein-erik-gullaksen/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20250327T143000
DTEND;TZID=Europe/Oslo:20250327T153000
DTSTAMP:20260528T044315
CREATED:20250522T082238Z
LAST-MODIFIED:20250522T082238Z
UID:618-1743085800-1743089400@cmyc.w.uib.no
SUMMARY:CCBIO Seminar – Göran Karlsson
DESCRIPTION:Welcome to the CCBIO seminar series in the spring term of 2025. Open to all in auditorium 4\, BBB. No registration necessary. Speaker is Göran Karlsson from Lund University\, Sweden\, on the topic “Exposing the stem cells of CML using single-cell genomics”. \nRead more at CCBIO’s website.
URL:https://cmyc.w.uib.no/event/ccbio-seminar-goran-karlsson/
END:VEVENT
END:VCALENDAR